A look at the Safe Harbor in light of recent court decisions
Foley Hoag attorneys presented an insightful webinar that delves into the dynamic and changing world of product development and the Hatch-Waxman Act’s patent infringement Safe Harbor provision under 35 U.S.C. §271(e)(1). This legal webinar is designed for anyone in the life sciences – whether you are involved in small molecules, biologics, devices or testing/tools – seeking to navigate the intricate landscape of intellectual property protection and patent infringement.
Our panel of lawyers discussed the following key areas:
Unpacking the Hatch-Waxman Act: Gain a comprehensive understanding of the Patent Safe Harbor's implications in the life sciences space.
Innovation Landscape: Explore the latest trends and developments in product development and how they intersect with patent protection.
Safe Harbor in Practice: Real-world case studies and examples that illustrate how the Patent Safe Harbor impacts life science products and their development.
Legal Insights: Learn from legal experts about best practices for protecting your intellectual property while operating within the confines of Patent Safe Harbor.
Please note that CLE credit is only valid for live attendance. At this time, we are not able to provide credit for recorded views. Please contact us for details.
We use cookies to enhance user experience, improve functionality and performance, and for analysis of website traffic. By clicking “accept”, you agree to the use of cookies. For more information about our cookie policy and the information we collect, please review our Privacy Statement.
Foley Hoag
Email Disclaimer
Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK," you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you.
If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Foley Hoag.
